Hisun Pharmaceutical Hangzhou Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS USP, with a corresponding US DMF Number 27202.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2013, and payment made on June 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II